Figure 2From: Assessing quality of life on the day of chemotherapy administration underestimates patients’ true symptom burden EORTC QLQ-C30 symptom scores at the hospital and 1 and 2 week(s) later at home. Dashed lines indicate that differences between hospital- and home-based assessments do not reach clinical relevance (i.e. a 5 point difference [11]); non-significant scores not shown.Back to article page